Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs, today announced the effective change of its corporate name and formal launch of its new corporate brand. In connection with the launch, the Company’s NYSE American ticker symbol has changed to “LCTX” and will be effective at the open of the market today
August 12, 2019
· 2 min read